Sangamo BioSciences

- NASDAQ:SGMO
Last Updated 2024-03-26
  • Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
  • Locations

    • Richmond CA
  • Total Funding (USD)

    74.0 million
  • Industries

    Software, Mobile Apps, Cyber Security
  • Security

    Type: ORD
    CUSIP: 800677106
    ISIN: US8006771062
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.